37.91
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVMD Giù?
Forum
Previsione
Revolution Medicines Inc Borsa (RVMD) Ultime notizie
What analysts say about Revolution Medicines Inc. stockSuperior stock selection - PrintWeekIndia
Revolution Medicines, Iambic Therapeutics Partner to Use AI for Novel RAS-Addicted Cancer Drug Discovery - Insider Monkey
What drives Revolution Medicines Inc. Equity Warrant stock priceTriple returns potential - Autocar Professional
What analysts say about Revolution Medicines Inc. Equity Warrant stockFastest-growing stock picks - PrintWeekIndia
Revolution Medicines publishes research on RAS G12D inhibitor - Investing.com
Revolution Medicines Inc. Equity Warrant Stock Analysis and ForecastHigh-octane financial growth - Autocar Professional
What drives Revolution Medicines Inc. stock priceBreakthrough stock performance - Autocar Professional
Is Revolution Medicines Inc. a good long term investmentMarket-leading capital gains - Autocar Professional
Revolution Medicines Announces Publication of a Peer-Reviewed Research Paper in Science on the Discovery and Development of Zoldonrasib, a RAS(ON) G12D-Selective Inhibitor - GlobeNewswire
Castle Biosciences, Revolution Medicines get FDA breakthrough statuses - MSN
Revolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman Sachs - MSN
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib - GlobeNewswire
Revolution Medicines Inc. Stock Analysis and ForecastConsistent wealth multiplication - jammulinksnews.com
Castle Bio, Revolution Medicines get FDA breakthrough statuses - Seeking Alpha
FDA grants breakthrough therapy designation to Revolution Medicines’ lung cancer drug - Investing.com Canada
How will RVMD's EPS trend in Q1 2025? - AInvest
Is Revolution Medicines Inc. Equity Warrant a good long term investmentConsistent high-performance stocks - jammulinksnews.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):